EBITDA Margin ratio Analysis of Alx Oncology Holdings - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Dec-23
Poor EBITDA Margin
0
Period Ending - Dec-22
Poor EBITDA Margin
0
Growth
0 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-6962.26
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Poor EBITDA Margin
0
EBITDA Margin Analysis of Alx Oncology Holdings
| Ebitda Margin Ratio of Alx Oncology Holdings with value of -6962.26 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
| Ebitda Margin Ratio of Alx Oncology Holdings with value of 0 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
| EBITDA Margin Ratio of ALXO has fallen by 0 % Compared to previous Financial Year. |
| EBITDA Margin Ratio with value of 0 was highest in Year Dec-23 in last Five Years. |
| EBITDA Margin Ratio with value of -3763.62 was lowest in Year Dec-20 in last Five Years. |
| Latest EBITDA Margin Ratio with value of 0 is Greater than Average EBITDA Margin of -830.95 in last five years. |
| Ebitda Margin of Alx Oncology Holdings is negative because of negative EBITDA in Trailing Twelve Months ended on Mar-24. |
Other EBITDA Margin Related Info of ALXO that may interest you.
Alx Oncology Holdings Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ALXO | 10.63 | 10.65 | 0.188 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical EBITDA Margin of Alx Oncology Holdings
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
|---|---|---|---|---|---|---|
| EBITDA Margin | 0 | 0 | 0 | -3763.62 | -391.14 | -641.27 |
| Change | 0 % | -862.22 % | 39.01 % |
FY Chart of EBITDA Margin of Alx Oncology Holdings
Note : All Data Generated at the End of Trading Hours (EOD Data)